NUVECTIS PHARMA INC. - COMMON STOCK

Nuvectis Pharma, Inc. Reports Fiscal Year 2021 Financial Results and Business Highlights

22 3 2022 07:30:00 提供 Nasdaq GlobeNewswire

Update - Nuvectis Pharma to Participate in a Fireside Chat at the 34th Annual Roth Conference

09 3 2022 09:12:44 提供 Nasdaq GlobeNewswire

Nuvectis Announces Positive Data for NXP900 in Triple Negative Breast Cancer Preclinical Models with an Integrin-Linked Kinase (ILK) Loss

22 2 2022 07:30:00 提供 Nasdaq GlobeNewswire

Nuvectis Pharma Announces Closing of $16,000,000 Upsized Initial Public Offering of Common Stock

08 2 2022 12:00:00 提供 Nasdaq GlobeNewswire

Nuvectis Pharma, Inc. Announces Pricing of $16,000,000 Upsized Initial Public Offering of Common Stock

04 2 2022 08:30:32 提供 Nasdaq GlobeNewswire